Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

The global rheumatoid arthritis drugs market was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Alarming rise in ...

Researchers, including a team from the University of Colorado, have made a fascinating discovery about rheumatoid arthritis ...

The Rheumatoid Arthritis Drugs/Therapeutics market revenue was $$ Million USD in 2022, grew to $$ Million USD in 2024, and will reach $$ Million USD in 2032, with a CAGR of $% during 2024-2032.

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

A Texan drug compounder cannot rely on federal law to avoid a lawsuit over copycat sales of a rheumatoid arthritis treatment, ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

The trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.

Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint ...